City Therapeutics Inc.
CTY | NASDAQ
$21.08
+$0.37 (+1.79%)
Nov 2, 2026, 11:48 AM ET · Market open
Fiscal Year Period Ending | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 | FY 2015 Dec 31, 2015 | FY 2014 Dec 31, 2014 |
|---|---|---|---|---|---|---|
Net Income | 1.83B | 1.67B | 1.66B | 1.09B | 1.07B | 970M |
Depreciation & Amortization | 1.36B | 1.44B | 1.58B | 1.68B | 1.84B | 1.97B |
Stock-Based Compensation | 26M | 24M | 27M | 22M | 21M | 21M |
Other Working Capital | -923M | -426M | -427M | -1.09B | -820M | -415M |
Other Non-Cash Items | 712M | 712M | -2.27B | 13M | -127M | -918M |
Deferred Income Tax | -100M | -48M | 773M | 123M | 189M | 228M |
Change in Working Capital | -497M | 1M | 663M | -270M | -405M | 534M |
Operating Cash Flow | 3.33B | 3.79B | 2.44B | 2.65B | 2.59B | 2.8B |
Capital Expenditures | -1.06B | -1.04B | -1.33B | -1.26B | -1.25B | -1.17B |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -668M | -113M | -108M | -75M | 27M | -86M |
Investing Cash Flow | -1.72B | -1.15B | -1.44B | -1.33B | -1.22B | -1.25B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -2M | -5M | -1M | -5M | -3M | -6M |
Dividend Paid | -1.6B | -1.28B | -1B | -1.3B | -1.35B | -1.4B |
Other Financial Acitivies | -12M | -1.36B | -3M | -16M | -24M | -158M |
Financial Cash Flow | -1.61B | -2.63B | -1B | -1.32B | -1.37B | -1.56B |
Net Cash Flow | -5M | 2M | -4M | 2M | -3M | -8M |
Free Cash Flow | 2.28B | 2.75B | 1.11B | 1.39B | 1.34B | 1.64B |
Adj. Free Cash Flow | 2.25B | 2.73B | 1.08B | 1.37B | 1.32B | 1.62B |
Maintenance CapEx | -1.06B | -1.04B | -1.33B | -1.26B | -1.18B | -1.13B |
Growth CapEx | n/a | n/a | n/a | n/a | -70.62M | -34.61M |
Owner Earnings | 2.28B | 2.75B | 1.11B | 1.39B | 1.41B | 1.67B |
Add to Watchlist
Select watchlists to add or remove CTY